Author

W. W. Schamel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Organism:mouse· 1

Frequent Co-Authors

S. Minguet· 2 shared A. Plach· 1 shared A.-M. Schaffer· 1 shared B. Salzer· 1 shared D. H. Busch· 1 shared D. Saltukoglu· 1 shared G. J. Fiala· 1 shared H. Stockinger· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

S. Minguet

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintMar 16, 2023

TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation

T. Peters, V. Muehlgrabner, R. M. H. Velasco Cardenas…·J. B. Huppa

This study shows TCR/CD3-based synthetic antigen receptors (TCC) have superior antigen sensitivity and activation fidelity compared to second-generation CARs.

DOI 10.1101/2023.03.16.532775

humanexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintApr 5, 2022

Kidins220 promotes thymic iNKT cell development by reducing TCR signals, but enhances TCR signals in splenic iNKT cells

L. A. Herr, G. J. Fiala, A.-M. Schaffer…·W. W. Schamel

This study shows Kidins220 modulates TCR signaling in thymic and splenic iNKT cells, promoting development in the thymus by reducing TCR signals but enhancing TCR signals in the periphery.

DOI 10.1101/2022.04.05.487104

mouseproteomics

𝕏 PostBluesky

BioengineeringbioRxivPreprintJun 25, 2021

Engineered chimeric T cell receptor fusion construct (TRuC)-expressing T cells prevent translational shutdown in SARS-CoV-2-infected cells

I. Godbole, K. Ciminski, O. S. Yousefi…·W. W. Schamel

Engineered TRuC T cells recognize and kill SARS-CoV-2-infected cells without causing cytotoxicity, rescuing translational shutdown.

DOI 10.1101/2021.06.25.449871

humanproteomics

𝕏 PostBluesky